2025.05.14
About StellarCell.Bio
A leading pioneer in regenerative medicine and cell therapy.
Company Overview: Founded in 2022, StellarCell BioMedicine Inc. is rooted in the field of regenerative medicine, specializing in the research, development and application of cell therapy technologies. We possess Taiwan’s largest intellectual property database of clinical data in cell therapy. This is not only our core competitive advantage but also a key asset that drives the development of the entire industry.
Read more Products
Starseed Biotech’s business scope includes new drug development, exosome-based formulations, aesthetic medicine and wound healing applications, skincare product development, and medical device services. Its main products include autologous and allogeneic exosome solutions, as well as collagen-based products.
01
Products
We hold a patented technology for cultivating exosomes derived from umbilical cord mesenchymal stem cells. Our exosomes are characterized by an ultra-high concentration (up to 200 billion particles per milliliter), exceptional quality (verified by third-party testing), and outstanding stability—achieved through a fully automated, GTP-compliant manufacturing process.
Company Profile Video
